Browsing by Subject "C07K 2317/76"

Now showing items 1-15 of 15

    • Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases 
      Prockop, Darwin J.; Oh, Joo Youn; Berkowitz, Barry; Roddy, Gavin W.; Rosa, Robert (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-10-23)
      The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
    • Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases 
      Prockop, Darwin J.; Oh, Joo Youn; Roddy, Gavin W.; Rosa, Robert; Berkowitz, Barry A. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2014-07-22)
      The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
    • Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases 
      Prockop, Darwin J.; Oh, Joo Youn; Berkowitz, Barry (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-01-17)
      The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
    • Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases 
      Prockop, Darwin J.; Oh, Joo Youn; Berkowitz, Barry; Roddy, Gavin W.; Rosa, Robert (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-08-15)
      The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
    • Compositions And Use Of A Fibrinogen Binding Motif Present In EFB And COA For Therapeutics And Vaccines Against Staphylococcus Aureus 
      Koo, Ya-Ping; Hook, Magnus; Arora, Srishtee; Visai, Livia; Bertoglio, Federico; Hust, Michael; Meier, Doris (United States. Patent and Trademark Office; Texas A&M University. Libraries, 8/9/2022)
      The present disclosure provides methods and composition including vaccines, monoclonal antibodies, polyclonal antibodies, chimeric molecule of an extracellular fibrinogen binding protein (Efb) and targeted agent delivery ...
    • Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use 
      Hook, Magnus; Xu, Yi; Speziale, Pietro; Visal, Livia; Casolini, Fabrizia; Patti, Joseph M.; Patel, Pratiksha; Domanski, Paul (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2007-07-10)
      Antibodies to the CNA protein and to other regions from the collagen binding domain, including domain CNA19, are provided, and antibodies produced in this manner have been shown to be cross reactive to both Staphylococcus ...
    • Fibronectin binding protein compositions and methods of use 
      Hook,Magnus; Patti, Joseph M.; House-Pompeo, Karen L.; Speziale, Pietro; Joh, Danny; Mcgavin, Martin J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2004-02-03)
      Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus ...
    • Fibronectin binding protein compositions and methods of use 
      Hook, Magnus; Patti, Joseph M.; House-pompeo, Karen L.; Speziale, Pietro; Joh, Danny; Mcgavin, Martin J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2006-10-31)
      Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus ...
    • Fusion Proteins (Seldegs) For Selectively Depleting Antigen-specific Antibodies And Methods Of Use Thereof 
      Ober, Elizabeth Sally Ward; Devanboyina, Venkata Siva Charan; Ober, Raimund Johannes (United States. Patent and Trademark Office; Texas A&M University. Libraries, 10/4/2022)
      The present disclosure includes a fusion protein, called a "Seldeg", including a targeting component that specifically binds to a cell surface receptor or other cell surface molecule at near-neutral pH, and an antigen ...
    • Mosaic chimeric viral vaccine particle 
      Mwangi, Waithaka; Waghela, Surya; Berghman, Luc (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-09-10)
      The present invention describes compositions and methods for priming protective immunity in the presence of pre-existing maternal antibody. In some embodiments, the invention contemplates simultaneously masking vaccines ...
    • Mosaic chimeric viral vaccine particle 
      Mwangi, Waithaka; Waghela, Surya; Berghman, Luc (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-11-17)
      The present invention describes compositions and methods for priming protective immunity in the presence of pre-existing maternal antibody. In some embodiments, the invention contemplates simultaneously masking vaccines ...
    • Mosaic Chimeric Viral Vaccine Particle 
      Mwangi, Waithaka; Waghela, Surya; Berghman, Luc (United States. Patent and Trademark Office; Texas A&M University. Libraries, 6/7/2022)
      The present invention describes compositions and methods for priming protective immunity in the presence of pre-existing maternal antibody. In some embodiments, the invention contemplates simultaneously masking vaccines ...
    • Perlecan domain V protects, repairs and restores ischemic brain stroke injury and motor function 
      Bix, Gregory J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-07-07)
      The disclosed invention relates to the use of perlecan domain V (DV) for the treatment of stroke, traumatic brain injury (TBI) or spinal cord injuries (SCI). In certain embodiments, fusion proteins of DV can be used for ...
    • Staphylococcal immunotherapeutics via donor selection and donor stimulation 
      Patti, Joseph M.; Foster, Timothy J.; Hook, Magnus (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2004-02-17)
      A method and composition for the passive immunization of patients infected with or susceptible to infection from Staphylococcus bacteria such as S. aureus and S. epidermidis infection is provided that includes the selection ...
    • Treatment of Staphylococcus aureus infections utilizing antibodies that bind to fibronectin binding proteins 
      Hook, Magnus; Patti, Joseph M.; House-pompeo, Karen L.; Speziale, Pietro; Joh, Danny; Mcgavin, Martin J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-07-03)
      Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus ...